Daikon Pharmaceuticals Private Limited
Founded in 2018 and headquartered in Delhi, India.
2018 | Delhi (India) | Active
Daikon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.90 M
- Revenue Growth 25.91%
- Profit Growth 68.64%
- Ebitda -135.90%
- Net Worth 38.55%
- Total Assets 17.45%
About Daikon Pharmaceuticals
Daikon Pharmaceuticals Private Limited (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 March 2018 (Seven years and one month 6 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.90 M.
Amrit Kaushal and Menka Kumari serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74994DL2018PTC330537
- Company No.
330537
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Trading
What products or services does Daikon Pharmaceuticals Private Limited offer?
Daikon Pharmaceuticals Private Limited offers a wide range of products and services, including Vitamins & Supplements, Vitamins A-Z.
Daikon Pharmaceuticals Private Limited
Explore comprehensive data for Daikon Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Daikon Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amrit Kaushal  | Managing Director | 08-Mar-2018 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Menka Kumari | Director | 08-Mar-2018 | Current |
Financial Performance of Daikon Pharmaceuticals.
Daikon Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 25.91% increase. The company also saw a substantial improvement in profitability, with a 68.64% increase in profit. The company's net worth Soared by an impressive increase of 38.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Daikon Pharmaceuticals?
Unlock access to Daikon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Concur Pharmaceuticals Private Limited
Amrit Kaushal is a mutual person
Charges (Loans)
Open Charges
₹4.90 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 0.49 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Aug 2024 | Others | ₹4.90 M | Open |
How Many Employees Work at Daikon Pharmaceuticals?
Unlock and access historical data on people associated with Daikon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Daikon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daikon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Daikon Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Daikon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Charges
A charge with Others amounted to Rs. 4.90 M with Charge ID 100972929 was registered on 04 Aug 2024.
- Balance Sheet
Daikon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Director Appointment
Amrit Kaushal was appointed as a Managing Director was appointed as a Managing Director on 08 Mar 2018 & has been associated with this company since 7 years 1 month .
- Director Appointment
Menka Kumari was appointed as a Director was appointed as a Director on 08 Mar 2018 & has been associated with this company since 7 years 1 month .
- Company Incorporation
Daikon Pharmaceuticals Private Limited was registered on 08 Mar 2018 with Roc Delhi & aged 7 years 1 month as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Daikon Pharmaceuticals Private Limited?
Daikon Pharmaceuticals Private Limited was incorporated on 08 Mar 2018.
What is authorized share capital and paid-up capital of Daikon Pharmaceuticals Private Limited?
The authorized share capital of Daikon Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Who are the current board members & directors of Daikon Pharmaceuticals Private Limited?
Currently 2 directors are associated with Daikon Pharmaceuticals Private Limited.
- Amrit Kaushal
- Menka Kumari
What is the registered address of Daikon Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Daikon Pharmaceuticals Private Limited is E-16/1530 Plot No- 68 Bapa Nagar Arya Samaj Road Karol Bagh, India, Delhi, 110005.
What is the corporate identification number (CIN) and company number of Daikon Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Daikon Pharmaceuticals Private Limited is U74994DL2018PTC330537 and the company number is 330537 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Daikon Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Daikon Pharmaceuticals Private Limited has risen by 25.91%.
What change has been observed in the net worth of Daikon Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Daikon Pharmaceuticals Private Limited has experienced an upsurge of 38.55%.
What are the total open charges for Daikon Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Daikon Pharmaceuticals Private Limited amount to ₹ 4.90 M.
When was the last Balance Sheet of Daikon Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Daikon Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records